Tumor-Induced Osteomalacia.
Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT.
Calcif Tissue Int. 2021 Jan;108(1):128-142. doi: 10.1007/s00223-020-00691-6. Epub 2020 Jun 5.
Tumor-induced osteomalacia.
Fukumoto S.
Panminerva Med. 2024 Jun;66(2):188-197. doi: 10.23736/S0031-0808.23.05047-4. Epub 2023 Dec 21.
Tumor-induced Osteomalacia: A Comprehensive Review.
Minisola S, Fukumoto S, Xia W, Corsi A, Colangelo L, Scillitani A, Pepe J, Cipriani C, Thakker RV.
Endocr Rev. 2023 Mar 4;44(2):323-353. doi: 10.1210/endrev/bnac026.
Tumor-induced osteomalacia.
Yin Z, Du J, Yu F, Xia W.
Osteoporos Sarcopenia. 2018 Dec;4(4):119-127. doi: 10.1016/j.afos.2018.12.001. Epub 2018 Dec 12.
Tumor-induced osteomalacia: An overview.
Jadhav SS, Shah R, Patil V.
Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101834. doi: 10.1016/j.beem.2023.101834. Epub 2023 Oct 20.
Tumor-induced osteomalacia.
Aoyama N, Nishiyama M, Namba H, Ikeuchi M, Fujimoto S, Terada Y.
QJM. 2023 Feb 14;116(1):78-79. doi: 10.1093/qjmed/hcac219.
Burosumab for the Treatment of Tumor-Induced Osteomalacia.
Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, Rauch F, Luca D, Cimms T, Roberts MS, San Martin J, Carpenter TO.
J Bone Miner Res. 2021 Apr;36(4):627-635. doi: 10.1002/jbmr.4233. Epub 2021 Jan 12.
Tumor-induced osteomalacia.
Annamalai AK, Shinto A, Aram S, Prabhu VA, Santhi R, Gopalakrishnan C, Chelian M, Srinivasan KG.
Kidney Int. 2022 Nov;102(5):1194. doi: 10.1016/j.kint.2022.04.042.
Tumor-induced Osteomalacia: A Systematic Review and Individual Patient's Data Analysis.
Rendina D, Abate V, Cacace G, D'Elia L, De Filippo G, Del Vecchio S, Galletti F, Cuocolo A, Strazzullo P.
J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3428-e3436. doi: 10.1210/clinem/dgac253.
Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases.
Bosman A, Palermo A, Vanderhulst J, De Beur SMJ, Fukumoto S, Minisola S, Xia W, Body JJ, Zillikens MC.
Calcif Tissue Int. 2022 Oct;111(4):367-379. doi: 10.1007/s00223-022-01005-8. Epub 2022 Jul 20.
